Biomérieux
Company Snapshot
Founded: 1963
Entity Type: Public
Employees: 13800
Region: Americas
Revenue: $3,779.5 Millions
Revenue Year: 2022
Headquarter: Marcy l'Etoile, France
Company Overview
BioMérieux is listed on the NYSE Euronext. The company focuses on diagnostic solutions (reagents, instruments, software and services) that determine the source of disease and contamination to improve patient health and ensure product safety.
Financial Highlights (FY 2022)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
Biomérieux In News
Company's Business Segments
- Clinical Applications : Immunoassays, Molecular biology, Microbiology, and Other ranges.
- Industrial Applications : Food and Pharma Quality Control
Applications/End User Industries
- Hospitals
- Laboratory
- Point Of Care
- Food Safety & Quality
- Pharma Quality Control
- Product Quality & Safety
- Customer Service
- Cybersecurity
BCC Research Beacon 